Grace Therapeutics, Inc GRCE

Healthcare

Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aneurysmal subarachnoid hemorrhage (aSAH) patients to address significant unmet medical needs. GTX-104 provides a convenient IV delivery of nimodipine in the intensive care unit, eliminating the need for nasogastric tube administration in unconscious or dysphagic patients. Its other pipeline drug candidates include GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia and GTX-101, which is a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia.

NDAQ:GRCE - Post by User

Grace Therapeutics, Inc

Bullboard Posts

Comment by Canadian_101on Dec 03, 2018 9:04am

135 Views

Post# 29053011

RE:ACST-NEWS OUT- Golden days are coming for ACST

President and Chief Executive Office, will be presenting, as well as meeting with investors.

Read more at https://www.stockhouse.com/companies/bullboard?symbol=v.acst&postid=29029326#X0ahmTx0Y20TRTm5.99

Have been watching this stock for awhile now, owned and sold 3 things so far and thankfully for a positive return, seems to me the stock is like a rollercoster, up, down and all over the place its been a great great stock to trade so far.

Hopefully the presentation goes well and investors sign up, should drive the stock higher, still holding off to rebuy back at 70 to 80 cents, was a good ride over the past few trading sessions.

Bullboard Posts

Gold vs. bitcoin, where should you invest?